Restelli, D.; Van Wallendael, C.; De Marneffe, N.; Damas, F.; Dulgheru, R.; Lancellotti, P.
One-Year Echocardiographic Follow-Up in Transthyretin Cardiac Amyloidosis: Impact of Tafamidis Treatment. J. Clin. Med. 2025, 14, 1538.
https://doi.org/10.3390/jcm14051538
AMA Style
Restelli D, Van Wallendael C, De Marneffe N, Damas F, Dulgheru R, Lancellotti P.
One-Year Echocardiographic Follow-Up in Transthyretin Cardiac Amyloidosis: Impact of Tafamidis Treatment. Journal of Clinical Medicine. 2025; 14(5):1538.
https://doi.org/10.3390/jcm14051538
Chicago/Turabian Style
Restelli, Davide, Céline Van Wallendael, Nils De Marneffe, François Damas, Raluca Dulgheru, and Patrizio Lancellotti.
2025. "One-Year Echocardiographic Follow-Up in Transthyretin Cardiac Amyloidosis: Impact of Tafamidis Treatment" Journal of Clinical Medicine 14, no. 5: 1538.
https://doi.org/10.3390/jcm14051538
APA Style
Restelli, D., Van Wallendael, C., De Marneffe, N., Damas, F., Dulgheru, R., & Lancellotti, P.
(2025). One-Year Echocardiographic Follow-Up in Transthyretin Cardiac Amyloidosis: Impact of Tafamidis Treatment. Journal of Clinical Medicine, 14(5), 1538.
https://doi.org/10.3390/jcm14051538